Digging Into the Growth in 340B Contract Pharmacies
Paula Chatterjee shares new research on the whether a popular discount drug program is reaching the patients it was designed to support.
Read MorePaula Chatterjee shares new research on the whether a popular discount drug program is reaching the patients it was designed to support.
Read MoreAteev Mehrotra explains why a trio of studies on overprescribing antiobiotics has him excited about telemedicine data.
Read MoreBianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.
Read MoreWe explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith.
Read MoreTaking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.
Read MoreStacie Dusetzina shares new research showing the difference in spending on Part B drugs in Medicare and Medicare Advantage.
Read MoreWe break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
Read MoreA doctor, a patient and a former federal official weigh in on Medicare’s recent move to restrict access to a new Alzheimer’s treatment.
Read More